CooperSurgical Inc. is a wholly-owned subsidiary of The Cooper Companies. Inc. and offers a portfolio of medical and surgical products and brands for women’s health care. The company markets its products to doctors, hospitals, and clinics featuring bone density tests, fertility, and surgical sterilization devices, neonatal respiratory products, obstetrics tools, and cancer screening products, among other things. The company has continued to invest in CooperSurgical’s business through the acquisition of companies and product lines for new or complementary products and services for the IVF process and within the OB/GYN space. CopperSurgical has strengthened its customer base and market position by developing products as well as acquiring companies that can be useful for the company’s growth. Owing to the investments being made in R&D activities, the company has been able to offer better and more innovative products. The company employs around 220 people in its R&D and manufacturing engineering departments. The company’s R&D activities include the advancement and expansion of CooperSurgical’s portfolio, design, and improvement of surgical procedure devices, genetic screening, and testing.
Cooper Surgicals, Inc and Olympus Corporation- Notable Market Players in Gynecology Device Market.
Olympus Corporation is among the established manufacturers of medical devices situated in Japan. The company operates through four of its business segments, medical systems, scientific solution segment, imaging segment, and others. The company has its offices as well as manufacturing units in regions such as Asia Pacific, Europe, America as well as the Middle East. The company has strong sales in North America and Asia, including Japan. The company has been investing in R&D activities that have helped in product innovation. The strong presence and broad portfolio of endoscopes, instruments, and imaging systems are considered to be the factors driving the company’s growth. The company has 106 subsidiaries and 2 affiliates, through which it caters to the demands of the local as well as global level. The company offers gynecological devices under the endoscopy and surgical segment covered under the medical division. Other products offered under the medical division of the company include, surgical and endotherapy. The demand for endoscopes offered by the company is significantly high in regions such as the Asia Pacific as well as Europe, due to the presence of established overseas offices that look after the sales of the products being offered by the company.
The Gynecology Device market is majorly comprised of top players involving CooperSurgical and Olympus Corporation.
The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the Gynecology Device Market:
| Year | News |
| Dec-2021 | Cooper Companies completed the previously announced definitive purchase agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services, and newborn stem cell storage (cord blood & cord tissue), for a purchase price of approximately $1.6 billion. |
| Oct-2021 | The newest Olympus DP series microscope camera—the DP23M monochrome camera—continues the series’ reputation for delivering high-quality images. With advanced features found on high-end microscope cameras, the DP23M monochrome camera provides premium fluorescence images at a reasonable cost. |
| Sep-2021 | Olympus announced the launch of the first devices in the new POWERSEALTM family of advanced bipolar surgical energy products. The POWER SEAL 5mm Curved Jaw Tissue Sealer and Divider, Double-Action devices meet the highest standards of clinical performance for advanced bipolar surgical energy devices by delivering consistent sealing reliability in an ergonomic, multifunctional design that promotes procedural efficiency. |
| Feb-2021 | Cooper Surgical announced a multi-year strategic collaboration, commencing this month, with Virtus Health, a leading global assisted reproductive services provider, to drive innovation, digitalization, and advancement of infertility treatment. Central to the collaboration will be the advancement of Precision Fertility – Virtus’ strategy to develop an innovative digital platform that harnesses the power of Virtus’ significant and unique data set and enhances clinical and scientific decisions with insights gained via artificial intelligence and machine learning. |
| Jan-2021 | Cooper Surgical has acquired Embryo Options, an established leader in cryo-storage software solutions for clinics and patients. The acquisition complements CooperSurgical’s comprehensive portfolio of innovative fertility offerings. Clinics partnered with Embryo Options benefit from automated billing and streamlined management of cryopreserved embryos, eggs, and sperm, resulting in increased collections, decreased specimen abandonment, and a reduced cost to manage cryo-inventory. Embryo Options also assists IVF centers with educating patients on their options for cryopreserved embryos, eggs, and sperm. Patients using the Embryo Options platform have access to online resources to learn more about continuing to store specimens, for subsequent ART treatment cycles, thawing and discarding, or donating specimens to other patients or for research. |
